Literature DB >> 12791885

Prevalence of human T-lymphotropic virus type 1 among blood donors from Mashhad, Iran.

Mohammad Reza Abbaszadegan1, Mehran Gholamin, Abbas Tabatabaee, Reza Farid, Massoud Houshmand, Morteza Abbaszadegan.   

Abstract

The city of Mashhad is the capital of Khorasan, the northeastern province of Iran, which has been recognized as an area where human T-lymphotropic virus type 1 (HTLV-1) infection is endemic. All serum samples from blood donors are routinely screened for HTLV-1 by using enzyme-linked immunosorbent assay (ELISA). In the present study, 28,926 donors (81.86% male and 18.14% female) with a mean age of 32 years (range, 18 to 65 years) were screened in a 6 months period (July to December 1999). Of these donors in the primary screening, 228 (0.78%) tested positive by ELISA. The positive samples were confirmed by Western blot (WB) analysis. The WB results indicated that, of 228 positive ELISA specimens, 91.2% (208 specimens) were HTLV-1, 4.82% (11 specimens) were HTLV, 3.5% (8 specimens) were indeterminate, and 0.44% (1 specimen) was not confirmed. HTLV refers to samples in which the complete viral antigen banding patterns on WB strips were not present. In order to further evaluate the detection methodologies used, the HTLV-1-seropositive samples, the indeterminant samples, and/or HTLV samples were examined and confirmed by PCR. The HTLV samples were determined to be HTLV-1, the remaining samples were indeterminant, and the negative sample could not be confirmed for HTLV-1 by PCR. The prevalence of HTLV-1 infection in our study was 0.77% among blood bank donors, which reconfirms the city of Mashhad as an area where the virus is endemic compared to other regions in the world. The incidence was correlated with increasing age, and it was higher in females than in males.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12791885      PMCID: PMC156501          DOI: 10.1128/JCM.41.6.2593-2595.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  13 in total

1.  Sensitive and specific polymerase chain reaction assays for diagnosis of human T-cell lymphotropic virus type I (HTLV-I) and HTLV-II infections in HTLV-I/II-seropositive individuals.

Authors:  W Heneine; R F Khabbaz; R B Lal; J E Kaplan
Journal:  J Clin Microbiol       Date:  1992-06       Impact factor: 5.948

2.  Sexual transmission of human T-lymphotropic virus type I (HTLV-I).

Authors:  E L Murphy; J P Figueroa; W N Gibbs; A Brathwaite; M Holding-Cobham; D Waters; B Cranston; B Hanchard; W A Blattner
Journal:  Ann Intern Med       Date:  1989-10-01       Impact factor: 25.391

3.  Human T-cell leukemia-lymphoma virus and adult T-cell leukemia.

Authors:  W A Blattner; K Takatsuki; R C Gallo
Journal:  JAMA       Date:  1983-08-26       Impact factor: 56.272

4.  Human T-lymphotropic virus type I among blood donors from Guadeloupe: donation, demographic, and biologic characteristics.

Authors:  F Rouet; C Foucher; M Rabier; I Gawronski; D Taverne; B Chancerel; O Casman; M Strobel
Journal:  Transfusion       Date:  1999-06       Impact factor: 3.157

5.  Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis.

Authors:  A Gessain; F Barin; J C Vernant; O Gout; L Maurs; A Calender; G de Thé
Journal:  Lancet       Date:  1985-08-24       Impact factor: 79.321

6.  A retrospective study on transmission of adult T cell leukemia virus by blood transfusion: seroconversion in recipients.

Authors:  K Okochi; H Sato; Y Hinuma
Journal:  Vox Sang       Date:  1984       Impact factor: 2.144

7.  Serological and molecular survey for HTLV-I infection in a high-risk Middle Eastern group.

Authors:  D Meytes; B Schochat; H Lee; G Nadel; Y Sidi; M Cerney; P Swanson; M Shaklai; Y Kilim; M Elgat
Journal:  Lancet       Date:  1990 Dec 22-29       Impact factor: 79.321

8.  HTLV-I maternal transmission in Martinique, using serology and polymerase chain reaction.

Authors:  N Monplaisir; C Neisson-Vernant; M Bouillot; M Duc-Dodon; E Ugarte; I Valette; Y Dezaphy; M Ouka; M G Eudaric; L Gazzolo
Journal:  AIDS Res Hum Retroviruses       Date:  1993-09       Impact factor: 2.205

9.  Immunological properties of a type C retrovirus isolated from cultured human T-lymphoma cells and comparison to other mammalian retroviruses.

Authors:  V S Kalyanaraman; M G Sarngadharan; B Poiesz; F W Ruscetti; R C Gallo
Journal:  J Virol       Date:  1981-06       Impact factor: 5.103

10.  Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma.

Authors:  B J Poiesz; F W Ruscetti; A F Gazdar; P A Bunn; J D Minna; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

View more
  25 in total

Review 1.  Clinical and Public Health Implications of Human T-Lymphotropic Virus Type 1 Infection.

Authors:  Nicolas Legrand; Skye McGregor; Rowena Bull; Sahar Bajis; Braulio Mark Valencia; Amrita Ronnachit; Lloyd Einsiedel; Antoine Gessain; John Kaldor; Marianne Martinello
Journal:  Clin Microbiol Rev       Date:  2022-02-23       Impact factor: 50.129

2.  Emerging infectious threats to the blood supply: seroepidemiological studies in iran - a review.

Authors:  Gharib Karimi; Ahmad Gharehbaghian; Mohammad Fallah Tafti; Vida Vafaiyan
Journal:  Transfus Med Hemother       Date:  2013-05-17       Impact factor: 3.747

3.  Epidemiological Aspects and World Distribution of HTLV-1 Infection.

Authors:  Antoine Gessain; Olivier Cassar
Journal:  Front Microbiol       Date:  2012-11-15       Impact factor: 5.640

4.  Adult T-cell leukemia: a review of epidemiological evidence.

Authors:  Masako Iwanaga; Toshiki Watanabe; Kazunari Yamaguchi
Journal:  Front Microbiol       Date:  2012-09-10       Impact factor: 5.640

Review 5.  The prevalence and significance of HTLV-I/II seroindeterminate Western blot patterns.

Authors:  Anna Abrams; Yoshimi Akahata; Steven Jacobson
Journal:  Viruses       Date:  2011-08-02       Impact factor: 5.048

Review 6.  Controversies in targeted therapy of adult T cell leukemia/lymphoma: ON target or OFF target effects?

Authors:  Rihab Nasr; Hiba El Hajj; Youmna Kfoury; Hugues de Thé; Olivier Hermine; Ali Bazarbachi
Journal:  Viruses       Date:  2011-06-14       Impact factor: 5.048

7.  Khorasan Disease: Prevalence of HTLV-I Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) In West Azarbaijan from 2004 to 2007.

Authors:  R Boostani; A Mellat Ardakani; H Ashrafi
Journal:  Iran Red Crescent Med J       Date:  2011-06-01       Impact factor: 0.611

8.  Epidemiology of human T-cell lymphotropic virus type 1 infection in blood donors, Israel.

Authors:  Shmuel Stienlauf; Vered Yahalom; Eli Schwartz; Eilat Shinar; Gad Segal; Yechezkel Sidi
Journal:  Emerg Infect Dis       Date:  2009-07       Impact factor: 6.883

9.  Guillain-Barré-like Syndrome, as a Rare Presentation of Adult T-cell Leukemia-Lymphoma (ATLL): A Case Report.

Authors:  Payam Sasannejad; Mahmoud Reza Azarpazhooh; Hossein Rahimi; Amir Moghaddam Ahmadi; Ali Mellat Ardakani; Hamid Reza Saber
Journal:  Iran Red Crescent Med J       Date:  2012-08-30       Impact factor: 0.611

10.  Animal models on HTLV-1 and related viruses: what did we learn?

Authors:  Hiba El Hajj; Rihab Nasr; Youmna Kfoury; Zeina Dassouki; Roudaina Nasser; Ghada Kchour; Olivier Hermine; Hugues de Thé; Ali Bazarbachi
Journal:  Front Microbiol       Date:  2012-09-21       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.